Dr. Toru Jay Seo, CEO of Lucidaim Co. Ltd. He obtained his PhD in Molecular and Cellular Pathology from Wake Forest University and completed his post-doctoral training in cardiovascular and metabolic diseases at Columbia University. He joined the faculty as an assistant professor in Department of Pediatrics at Columbia University Medical Center where he performed independent academic research in the field of lipid metabolism. In 2007, he moved to pursue a R&D career in the leading industries such as GSK, MERCK, TAISHO and PFIZER where his roles came to include project leader, global scientific committee member, team lead, and later on in business development and corporate strategic planning. Being a seasoned drug hunter in major pharma, he moved to an APAC head of Search and Evaluation, Worldwide Business Development, Chief Business Office, Pfizer Inc. in 2019. After leaving the pharma industry with a vast experience in business development and R&D in 2021, he created his own drug discovery biotech and investment farm to pursue his vision of stimulating life science community. He also assumed the roles as an external counselor, advisor of biotech ventures and VCs while being a visiting professor of Osaka University and a visiting lecturer of Waseda Business School, Waseda University. He is an author of more than 70 peer-reviewed and review articles.

What I expect of LINK-J

Spread the positive vibes

Message to LINK-J Special Members

Be defiant and go beyond the norm